Clariant : Presentation Baader Investment Conference, Munich 20200922 EN

Baader Investment Conference Munich

22 September 2020

2Baader Investment Conference, 22 September 2020

Disclaimer

This presentation contains certain statements that are neither reported financial results nor other historical information.

This presentation also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements.

Many of these risks and uncertainties relate to factors that are beyond Clariant's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors;

the Company's ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document.

Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.

Who we are

4Baader Investment Conference, 22 September 2020

Clariant is a globally leading company in specialty chemicals

4 399	692	3	17 223
Sales 2019 (CHF m)	EBITDA12019 (CHF m)	Core Business Areas	Employees 2019
from continuing operations	from continuing operations		of total Group including
			discontinued operations

38	15.7%	118
Net result 2019 (CHF m)	EBITDA margin12019	Production sites worldwide
of total Group including	from continuing operations	of total Group including
discontinued operations		discontinued operations

1excluding a CHF 231 million provision for an ongoing competition law investigation by the European Commission

5Baader Investment Conference, 22 September 2020

Clariant's 5 pillar strategy with enhanced product and

solution offerings to increase performance

OUR WAY TO MEET OUR OBJECTIVES

1

2

3

4

5

FOCUS ON	ADD VALUE	REPOSITION	INTENSIFY	INCREASE
INNOVATION	WITH	PORTFOLIO	GROWTH	PROFITABILITY
AND R&D	SUSTAINABILITY

PEOPLE EXCELLENCE

6Baader Investment Conference, 22 September 2020

Care Chemicals

MID-TERM TARGETS:
Sales growth expectation p.a.	5-7%
EBITDA margin ambition	19-21%

BUSINESS AREA PROFILE

CONSUMER CARE

(~50% Care Chemicals sales)

PERSONAL CARE Ingredientsincl. Naturals and premium cosmetic formulationsto support hair & skin care globally, as well as solutions for specific applications (i.e. men's care, cosmetics, hair styling, and sun protection)

HOME CARE

Sustainable ingredients and solutions ranging from soil release polymersthat protect fibers to silver biocides, from special amine oxidesto low foaming surfactants

CROP PROTECTION

Includes the improvement of emulsifiersand dispersing agentsas well as the development of adjuvantsleading to enhanced pesticide performance

INDUSTRIAL APPLICATIONS(~50% Care Chemicals sales)

PAINTS & COATINGS

Solutions that conform to the latest regulatory and ecolabel requirements with a complete range of multifunctional additives such as wetting and dispersing agents, stabilizers and neutralizers

AVIATION- Runway and aircraft deicing solutions with new recycling options

CONSTRUCTION CHEMICALS

Selected range of polyglycols for superplasticizersand concrete additivesfor the concrete admixture market

INDUSTRIAL LUBRICANTS

Broad product portfolio including synthetic base fluids, low foaming emulsifiers, componentsand lubricant additives

7Baader Investment Conference, 22 September 2020

Catalysis

MID-TERM TARGETS:
Sales growth expectation p.a.	6-9%
EBITDA margin ambition	26-30%

BUSINESS AREA PROFILE

PETROCHEMICALS & REFINING CATALYSTS

Tailor-made solutions for main petrochemical building blocks, such as ethylene, propylene(incl. Propane Dehydrogenation and methanol-to- propylene), butadieneand styrene

SYNGAS CATALYSTS

Utilized globally for cost- and energy-efficient production of ammonia, methanoland hydrogenas well as for fuel cells, gas processingand various gas-to-liquid,coal-to-liquid and biomass-to-liquid processes

CHEMICAL CATALYSTS

For decades Clariant has developed catalysts and catalyst technology for selective oxidation and hydrogenation processes. These processes are key methods for the production of intermediates and specialty chemicals (i.e. the production of fatty alcohols, formaldehyde, maleic anhydride, phthalic anhydride and sulfuric acid)

BIOFUELS & DERIVATIVES

Includes sunliquid®technology which is at the forefront of the commercialization and licensing of cellulosic ethanol technology

for the production of second generation biofuel

8Baader Investment Conference, 22 September 2020

Natural Resources

MID-TERM TARGETS:
Sales growth expectation p.a.	5-7%
EBITDA margin ambition	18-20%

BUSINESS AREA PROFILE

OIL AND MINING SOLUTIONS

A leading provider of tailor-made solutions within oil production, mining, and refinerywith hydrocarbon know-how for oilfield production incl. offshore and deep water, chemical management, crude and fuel transportation, the optimization of fuel blending in refineries and upgrading fuels by applying tailored additives, which is also applied to improving recovery and grade in mining operations

FUNCTIONAL MINERALS

A leading provider of specialty products based on bentoniteincluding oil purification, foundry additives and cargo & device protection applications covering the entire value chain form exploration / mining

ADDITIVES

A major supplier of flame retardants, performance additivesand advanced surface solutionsfor functional effects in plastics, coatings, inks and consumer applications addressing also e-mobility, digitalization and recycling needs

Focus on innovation and sustainability

10Baader Investment Conference, 22 September 2020

Our commitment to Innovation

INNOVATION FIGURES FOR END OF 2019

173		3.9%	> 3.5%	5 400
R&D		R&D	Growth through innovation1,3	Patents1
in CHF m1		in % of sales1
						RESOURCES &
8	> 50	> 1 050	> 125			ENERGY
R&D	Technical	People in R&D2	Scientific collaborations2
Centers2	Application
	Centers2			ENVIRONMENT
				PROTECTION		GLOBALIZATION &
						URBANIZATION

1continuing operations 2total group

3contains the contribution to growth of the innovation portfolio from both Top Line Innovation and Life Cycle Innovation. Potential cannibalization of existing sales by Life Cycle Innovation has not been excluded.

11Baader Investment Conference, 22 September 2020

Our commitment to Sustainability

2025 ENVIRONMENTAL TARGETS1

FACTS AND FIGURES

75%

of product portfolio screened based on 36 sustainability criteria2

~ 80%

of raw material suppliers covered by sustainability assessments3

1based on 2013 values (in % t produced goods); 2for continuing operations; 3including discontinued operations

ACKNOWLEDGEMENTS

> 200

products excelled

with the EcoTain®label2

2012

0.33

2019

0.15

Low Lost Time

Accident Rate

Reposition portfolio

13Baader Investment Conference, 22 September 2020

Clariant's transformation program execution is in motion

DIVESTMENT OF

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS

Returned capital to shareholders

Healthcare Packaging

Masterbatches		Strengthen balance sheet
Pigments	In progress	Invest in innovation and sustainability

Clariant's successful step by step delivery of transformationtoward a stronger portfolio has gained investor confidence

FOCUS ON

SPECIALTY BUSINESSES

CARE CHEMICALS	Specialty portfolio
	with

Intensified growth

CATALYSIS

Enhanced earnings quality

NATURAL RESOURCES

Maximized cash generation

Intensify growth

15Baader Investment Conference, 22 September 2020

Growth through local innovation, footprint and partnerships China as key region for future development

H1 2020 SALES BY REGION

Total continuing operations in CHF m

ASIA-PACIFIC		EUROPE
526 / -1%*			652 / -13%*
				Germany 221 / -7%*
China 188 / +3%*

MEA

139 / -1%*

CLARIANT POSITIONING

IN CHINA

	Jianping
Yinchuan	Beijing
Cangzhou	Panjin

Qingdao

Zhenjiang

Shanghai

Jiaxing

EXAMPLE OF SUCCESSFUL DEVELOPMENT IN CHINA

Construction of new CATOFIN™plant- Jiaxing, Zhejiang Province

• Represents an investment to

further strengthen position in

China and underpins commitment

to future growth

• New facility will produce

CATOFIN™catalyst for propane

dehydrogenation

• CATOFIN™delivers superior

LATIN AMERICA	NORTH AMERICA
243 / +11%*	385 / -9%*

Kunming

Taipei

Huizhou

production output compared to

alternative technologies

Brazil 98 / +9%*

Shenzen

Guangzhou

• Construction to commence in Q3

2020 and be at full production

capacity by 2022

Current performance

17Baader Investment Conference, 22 September 2020

Update on COVID-19 mitigation measures

EMPLOYEE SAFETY

Cases of infection continue to be kept low as a result of social distancing, home office arrangements (i.e. corporate functions split into 2 teams) and travel bans governed by Clariant's GEM organization

SUPPORT FOR COMMUNITIES AND STAKEHOLDERSDistribution of face masks to all employees, production of disinfectants in Gendorf, Germany

PRESERVATION OF BUSINESS CONTINUITY

Only minimal disruption caused by temporary production site closures while maintaining a close collaboration with customers and key suppliers

PERFORMANCE IMPROVEMENT

Ongoing centrally run programs to optimize cash and reduce cost

• Capex cut ofnon-strategic and non-safety-related projects
• Working capital optimization, especially inventory and close credit control
• Spend avoidance, travel reduction and operational flexibilization

RESUMPTION OF EFFICIENCY PROGRAMReduction of c. 600 positions for c. CHF 50 m savings in continuing operations

BASED ON A STRONG BALANCE SHEET

AND FINANCIAL FLEXIBILITY

Cover up to show you care

WEAR A MASK

18Baader Investment Conference, 22 September 2020

First half year and second quarter 2020 - Highlights

H1 2020 vs. H1 2019, figures from continuing operations

SALES	1 945	-5%
	in CHF m	in LC1y-o-y	15.0%
EBITDA	292	+186%
	in CHF m	in CHF y-o-y	margin
before	309	-13%	15.9%
EBITDA
exceptional items	in CHF m	in CHF y-o-y	margin
NET RESULT2	90	n. m.
	in CHF m	in CHF y-o-y
OPERATING	89	-21%
CASH FLOW2
	in CHF m	in CHF y-o-y

Q2 2020 vs. Q2 2019, figures from continuing operations

SALES	926	-4%
	in CHF m	in LC1y-o-y	14.6%
EBITDA	135	n. m.
	in CHF m	in CHF y-o-y	margin
before	146	-10%	15.8%
EBITDA
exceptional items	in CHF m	in CHF y-o-y	margin

1in local currency; 2including discontinued operations

19Baader Investment Conference, 22 September 2020

Resilient performance based on specialty portfolio and mitigations

CONTINUING OPERATIONS PERFORMANCE

H1 2020 in CHF m

RESILIENT DEVELOPMENT OF SPECIALTY PORTFOLIO

BUSINESS AREA		2020		2019
PERFORMANCE

H1 2020 in CHF m,EBITDA margin in % (underlying margin)

Sales	1 945
			-5% LC1
2 229
EBITDA		292
102	3332
EBITDA	15.0%
margin	4.6%		14.9%2

Q2 2020 in CHF m

Sales	926	-4% LC1
1 065
	135

EBITDA	H1 2020	15.0%
Margin	Q2 2020	14.6%

Higher EBITDA margin in H1 2020 at

15.0% vs. 14.9%2

Sales	734
850
EBITDA	120 16.3% (18.1%)
	150	17.6% (18.1%)
Sales	392
	432
EBITDA	68			17.3% (19.1%)
		19.4% (20.4%)
	84

-6% LC1

-4% LC1

EBITDA
-82	1492
EBITDA	14.6%
margin	14.0%2

in a challenging environment with 5% LC1sales decline

Higher EBITDA margin in Q2 2020 at

2

Sales

819

947

116 14.2% (16.8%)

-5% LC1

14.6% vs. 14.0%

EBITDA

148 15.6% (15.7%)

1in local currency 2excluding CHF 231 million provision for a competition law investigation by the European Commission

Outlook

21Baader Investment Conference, 22 September 2020

Focus on resilient performance amid COVID-19 pandemic

and on continued transformation; Mid-term guidance confirmed

Clariant anticipates Q3 2020 sales and profitability to be more adversely affected by weak demand amid the COVID-19 pandemic

Clariant continues to maintain stringent cost and cash management measures

in addition to resuming its efficiency program, which will lead to a cost-base reduction in excess of CHF 50 m. This will demonstrate resilience and will underpin Clariant's progress to its

mid-term targets

Although the current challenging environment will have a negative impact on the 2020 results, Clariant expects its continuing businesses to achieveabove-marketgrowth, higher profitability and stronger cash generation in themid-termbased on its focused, high value specialty portfolio

Clariant continues to execute its strategy and

transformation programfollowing the successful completion of the sale of Masterbatches in July 2020 and Healthcare Packaging in October 2019 and is preparing the planned divestment of Pigments

Back-up Slides

23Baader Investment Conference, 22 September 2020

Clariant builds on a focused, high value specialty portfolio and strong regional presence

SALES BY BUSINESS AREA	SALES BY REGION
In CHF m and in % of continuing operations	Total continuing operations sales 2019
	in CHF m
Total continuing operations sales 2019: CHF 4 399 m

Emerging markets

Mature markets

		ASIA-PACIFIC		EUROPE
	1 155 (26%)	1 488 (34%)
CARE	+8%*	+1%*
	China 399 / +0%*		Germany 507 / -1%*
CHEMICALS
1 600 (36%)	CATALYSIS

925(21%)

	MEA
	338 (8%)
NATURAL	+3%*
RESOURCES
1 874 (43%)	LATIN AMERICA	NORTH AMERICA
	556(12%)	862(20%)
	+13%*	-5%*

Brazil 234 / + 4%*

* In local currency

24Baader Investment Conference, 22 September 2020

Cross Business Areas

CLARIANT WINS 2020 CHINA GOLDENBEE CSR AWARD

EcoCircle advocacy and commitment to circular plastics economy recognized with GoldenBee Enterprise (One Star) honor. Details on EcoCircle and relevant solutions documented in »2020 GoldenBee CSR Competitiveness Case Study Collection«. Award presented during the 15thChina CSR International Forum-cum-GoldenBee CSR China Honor Roll

NEW CLARIANT ADDITIVE SOLUTIONS WILL ADD MORE THAN JUST A

FINISHING TOUCH TO INDUSTRIAL COATINGS

Protecting and prolonging with the environment in mind: boosting performance of heavy-duty coatings while reducing environmental impact. New high-performancehalogen-free flame retardant extends fire resistance of intumescent coatings for steel structures - webinar June 17, 2020. Light stabilizer prolonging service life of automotive and industrial coatings, plus shelf-life extender for waterborne intumescents and new REACH-compliant PTFE waxes

CLARIANT RAISES THE BAR FOR SUSTAINABLE COATINGS SOLUTIONS WITH NEW ADDITIVES, DISPERSANTS AND PIGMENTS AVAILABLE NOWClariant's next-generation sustainable solutions front and center through 2020 and beyond. Pigment paste producers get an efficiency boost with new polymeric dispersing agent. New wood coating additives deliver a high-performance finish, shine and color to U.S. industry and DIY

25Baader Investment Conference, 22 September 2020

First half year 2020 - Sales and EBITDA by Business Area

FIRST HALF YEAR		SALES TO 3RDPARTIES			EBITDA
in CHF m	2020	2019	% LC*	2020***	2019	% CHF
Care Chemicals	734	850	-6%	120	150	-20%
margin				16.3%	17.6%
Catalysis	392	432	-4%	68	84	-19%
margin				17.3%	19.4%
Natural Resources	819	947	-5%	116	148	-22%
margin				14.2%	15.6%
Business Areas Total	1 945	2 229	-5%	304	382
Corporate	-	-		-12	-49
Total Continuing Operations	1 945	2 229	-5%	292	333	-12%
margin				15.0%	14.9%
Provision**					-231
Total Continuing	1 945	2 229		292	102
margin				15.0%	4.6%
Discontinued	941	1 109	-9%	67	91	-26%
Total Group	2 886	3 338	-6%	359	193	86%

*in local currency **CHF 231 million provision for a competition law investigation by the European Commission (EC) ***2020 EBITDA figures include a total of CHF 55 million reversal for a competition law investigation by the EC (in Corporate) and CHF 58 million provision for the efficiency program (CHF 13 million to Care Chemicals, CHF 5 million to Catalysis, CHF 21 million to Natural Resources and CHF 19 million to Corporate)

26Baader Investment Conference, 22 September 2020

Full year 2019 - Sales and EBITDA by Business Area

FULL YEAR		SALES TO 3RDPARTIES			EBITDA
in CHF m	2019	2018	% LC*	2019	2018	% CHF
Care Chemicals	1 600	1 665	-1%	282	314	-10%
margin				17.6%	18.9%
Catalysis	925	861	+9%	212	185	+15%
margin				22.9%	21.5%
Natural Resources	1 874	1 878	+4%	305	271	+13%
margin				16.3	14.4%
Business Areas Total	4 399	4 404	+3%	799	770
Corporate	-	-		-107	-163
Total Continuing Operations				692	607	+14%
margin				15.7%	13.8%
Provision**				-231
Total Continuing	4 399	4 404	+3%	461	607	-24%
margin				10.5%	13.8%
Discontinued	2 127	2 219	-2%	158	264	-40%
Total Group	6 526	6 623	+1%	619	871	-29%

*in local currency **CHF 231 million provision for a competition law investigation by the European Commission

27Baader Investment Conference, 22 September 2020

First half year 2020 - Key financials

		2020		2019
Continuing operations	CHF m	% of sales	CHF m	% of sales
Sales	1 945	100.0%	2 229	100.0%
Local currency growth	-5%		4%
Organic growth*	-5%		4%
Acquisitions/divestitures	0%		0%
Currencies	-8%		-4%
Gross profit	624	32.1%	696	31.2%
EBITDA	292	15.0%	102	4.6%
EBITDAbefore exceptional items	309	15.9%	355	15.9%
EBIT	154	7.9%	-47
EBITbefore exceptional items	172	8.8%	206	9.2%
Net result**	90		-101
Operating cash flow**	89		113
Sales from discontinued operations	941	100.0%	1 109	100.0%
Net income from discontinued operations	15		32

*organic growth: volume and price effects excluding the impact of changes in foreign currency exchange rates and acquisitions/divestments ** including discontinued operations

28Baader Investment Conference, 22 September 2020

First half year 2020 - Total Group consolidated statements of cash flows

CHF m	2020	2019
Net result	90	-101
Depreciation, amortization and impairment	138	184
Payments for restructuring	-11	-16
Other	141	115
Cash flow before changes in working capital	358	182
Changes in working capital and provisions	-221	-2
Income taxes paid	-48	-67
Operating cash flow	89	113
Cash flow from investing activities	199	-108
thereof: property, plant and equipment	-96	-87
thereof: changes in current financial assets and short-term deposits	293	-35
thereof: acquisitions, disposals and other	2	14
Cash flow before financing	288	5

29Baader Investment Conference, 22 September 2020

The Executive Committee

HARIOLF KOTTMANN Executive Chairman1

Responsibilities:

Group Auditing (together with Chairman of Audit Committee), Group Communications, Group Compliance, Group Human Resources, Group Legal

HANS BOHNEN	BERND HOEGEMANN	STEPHAN LYNEN
Executive Vice President &	Executive Vice President &	Executive Vice President &
Chief Operating Officer	Chief Transformation Officer	Chief Financial Officer
Responsibilities:	Responsibilities:	Responsibilities:
Business Line Biofuels & Derivatives,	Business Units Functional Minerals,	Corporate Accounting, Corporate
Business Units Additives, Catalysts,	Masterbatches and Pigments,	Controlling, Corporate Mergers &
Industrial & Consumer Specialties	Clariant Excellence, Corporate	Acquisitions, Corporate Tax,
and Oil and Mining Services,	Planning & Strategy, Corporate	Corporate Treasury, Global Business
Digital4Clariant, Group Technology &	Sustainability & Regulatory Affairs,	Services, Group Finance Services,
Innovation, and the regions Latin	Group Procurement Services,	Group Investor Relations, Group
America and North America	Project Clariant 2021, Divestment	Information Technology, and the
	Projects, and the region Asia-Pacific	region Europe, Middle East & Africa

1ad interim - no longer than 24 months and therefore no longer than July 24, 2021

30Baader Investment Conference, 22 September 2020

Investor Relations contacts

Maria Ivek

Senior Investor Relations Officer

Alexander Kamb

Investor Relations Officer

Phone:[phone]

Email: [e-mail]